{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T21:50:46Z","timestamp":1776894646503,"version":"3.51.2"},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/j.juro.2013.12.001","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T02:15:22Z","timestamp":1386641722000},"page":"242-251","source":"Crossref","is-referenced-by-count":31,"title":["Potential Significance of EMP3 in Patients with Upper Urinary Tract Urothelial Carcinoma: Crosstalk with ErbB2-PI3K-Akt Pathway"],"prefix":"10.1097","volume":"192","author":[{"given":"Yi-Wen","family":"Wang","sequence":"first","affiliation":[{"name":"Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei-Ming","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen-Jeng","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Urology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Republic of China"},{"name":"Department of Urology, Kaohsiung Municipal Hsiao-Kang Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China"},{"name":"Department of Urology, Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan, Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chee-Yin","family":"Chai","sequence":"additional","affiliation":[{"name":"Department of Pathology, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan, Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hsiao-Sheng","family":"Liu","sequence":"additional","affiliation":[{"name":"Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China"},{"name":"Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ming-Derg","family":"Lai","sequence":"additional","affiliation":[{"name":"Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China"},{"name":"Department of Biochemistry and Molecular Biology, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan-Haw","family":"Chow","sequence":"additional","affiliation":[{"name":"Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China"},{"name":"Department of Pathology, College of Medicine, National Cheng Kung University, Tainan, Taiwan, Republic of China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2013.12.001_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.tig.2006.06.007","article-title":"Gene amplification in cancer","volume":"22","author":"Albertson","year":"2006","journal-title":"Trends Genet"},{"key":"10.1016\/j.juro.2013.12.001_bib2","doi-asserted-by":"crossref","first-page":"4285","DOI":"10.1073\/pnas.89.10.4285","article-title":"Humanization of an anti-p185HER2 antibody for human cancer therapy","volume":"89","author":"Carter","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.juro.2013.12.001_bib3","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S0002-9440(10)64592-0","article-title":"High-throughput tissue microarray analysis of cyclin E\u00a0gene amplification and overexpression in urinary bladder cancer","volume":"157","author":"Richter","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/j.juro.2013.12.001_bib4","doi-asserted-by":"crossref","first-page":"4319","DOI":"10.1038\/sj.onc.1210195","article-title":"Overexpression of SERTAD3, a putative oncogene located within the 19q13 amplicon, induces E2F activity and promotes tumor growth","volume":"26","author":"Darwish","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.juro.2013.12.001_bib5","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1158\/0008-5472.CAN-06-3387","article-title":"Intersex-like (IXL) is a cell survival regulator in pancreatic cancer with 19q13 amplification","volume":"67","author":"Kuuselo","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2013.12.001_bib6","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1038\/sj.onc.1209353","article-title":"The human homologue of the RNA polymerase II-associated factor 1 (hPaf1), localized on the 19q13 amplicon, is associated with tumorigenesis","volume":"25","author":"Moniaux","year":"2006","journal-title":"Oncogene"},{"key":"10.1016\/j.juro.2013.12.001_bib7","doi-asserted-by":"crossref","first-page":"4149","DOI":"10.1158\/0008-5472.CAN-05-3089","article-title":"The kinase Mirk\/Dyrk1B mediates cell survival in pancreatic ductal adenocarcinoma","volume":"66","author":"Deng","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2013.12.001_bib8","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.4161\/cbt.7.11.6840","article-title":"Copy number alterations in pancreatic cancer identify recurrent PAK4 amplification","volume":"7","author":"Chen","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.juro.2013.12.001_bib9","doi-asserted-by":"crossref","first-page":"2680","DOI":"10.1038\/sj.onc.1206349","article-title":"cDNA microarray analysis of genes associated with ERBB2 (HER2\/neu) overexpression in human mammary luminal epithelial cells","volume":"22","author":"Mackay","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.juro.2013.12.001_bib10","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1158\/0008-5472.CAN-12-2440","article-title":"Trastuzumab-resistant cells rely on a HER2-PI3K-FoxO-Survivin axis and are sensitive to PI3K inhibitors","volume":"73","author":"Chakrabarty","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2013.12.001_bib11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3346\/jkms.2009.24.1.97","article-title":"EMP3 overexpression in primary breast carcinomas is not associated with epigenetic aberrations","volume":"24","author":"Zhou","year":"2009","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.juro.2013.12.001_bib12","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0959-8049(01)00110-1","article-title":"Overexpression of HER-2\/neu enhances the sensitivity of human bladder cancer cells to urinary isoflavones","volume":"37","author":"Su","year":"2001","journal-title":"Eur J\u00a0Cancer"},{"key":"10.1016\/j.juro.2013.12.001_bib13","first-page":"1764","article-title":"Overexpression of CDC25A phosphatase is associated with hypergrowth activity and poor prognosis of human hepatocellular carcinomas","volume":"9","author":"Xu","year":"2003","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2013.12.001_bib14","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.ajpath.2012.05.024","article-title":"Overexpression of TG-interacting factor is associated with worse prognosis in upper urinary tract urothelial carcinoma","volume":"181","author":"Yeh","year":"2012","journal-title":"Am J Pathol"},{"key":"10.1016\/j.juro.2013.12.001_bib15","first-page":"1957","article-title":"Expression profiles of ErbB family receptors and prognosis in\u00a0primary transitional cell carcinoma of the urinary bladder","volume":"7","author":"Chow","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2013.12.001_bib16","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/j.ajpath.2013.05.015","article-title":"Epithelial membrane protein 2 is a prognostic indictor for patients with urothelial carcinoma of the upper urinary tract","volume":"183","author":"Wang","year":"2013","journal-title":"Am J Pathol"},{"key":"10.1016\/j.juro.2013.12.001_bib17","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.ydbio.2005.09.003","article-title":"Epithelial membrane protein-2 regulates surface expression of alphavbeta3 integrin in the endometrium","volume":"287","author":"Wadehra","year":"2005","journal-title":"Dev Biol"},{"key":"10.1016\/j.juro.2013.12.001_bib18","doi-asserted-by":"crossref","first-page":"24865","DOI":"10.1074\/jbc.M302381200","article-title":"Direct interaction of focal adhesion kinase with p190RhoGEF","volume":"278","author":"Zhai","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.juro.2013.12.001_bib19","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1517\/14728220902988549","article-title":"EMP3 as\u00a0a candidate tumor suppressor gene for solid tumors","volume":"13","author":"Fumoto","year":"2009","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.juro.2013.12.001_bib20","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1158\/0008-5472.CAN-04-4283","article-title":"EMP3, a\u00a0myelin-related gene located in the critical 19q13.3 region, is epigenetically silenced and exhibits features of a candidate tumor suppressor in glioma and neuroblastoma","volume":"65","author":"Alaminos","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.juro.2013.12.001_bib21","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.urology.2005.06.117","article-title":"Frequency and\u00a0clinicopathologic correlates of ErbB1, ErbB2, and ErbB3 immunoreactivity in urothelial tumors of upper urinary tract","volume":"66","author":"Tsai","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.juro.2013.12.001_bib22","doi-asserted-by":"crossref","unstructured":"Nielsen K, Heegaard S, Vorum H et\u00a0al: Altered expression of CLC, DSG3, EMP3, S100A2, and SLPI in corneal epithelium from keratoconus patients Cornea 2005; 24: 661.","DOI":"10.1097\/01.ico.0000153556.59407.69"},{"key":"10.1016\/j.juro.2013.12.001_bib23","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.bcp.2007.11.006","article-title":"Gene expression profiling elucidates a specific role for RARgamma in the\u00a0retinoic acid-induced differentiation of F9 teratocarcinoma stem cells","volume":"75","author":"Su","year":"2008","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.juro.2013.12.001_bib24","doi-asserted-by":"crossref","unstructured":"Skandalis SS, Afratis N, Smirlaki G et\u00a0al: Cross-talk between estradiol receptor and EGFR\/IGF-IR signaling pathways in estrogen-responsive breast cancers: focus on the role and impact of proteoglycans. Matrix Biol 2013; Epub ahead of print.","DOI":"10.1016\/j.matbio.2013.09.002"},{"key":"10.1016\/j.juro.2013.12.001_bib25","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1111\/j.1365-2559.2011.03856.x","article-title":"Activation of the PI3K\/Akt\/mTOR pathway correlates with tumour progression and reduced survival in patients with urothelial carcinoma of the urinary bladder","volume":"58","author":"Sun","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/j.juro.2013.12.001_bib26","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1006\/geno.1998.5238","article-title":"Chromosomal mapping of Tmp (Emp1), Xmp (Emp2), and Ymp (Emp3), genes encoding membrane proteins related to Pmp22","volume":"49","author":"Ben-Porath","year":"1998","journal-title":"Genomics"},{"key":"10.1016\/j.juro.2013.12.001_bib27","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.exer.2012.06.002","article-title":"Anti-EMP2 diabody blocks epithelial membrane protein 2 (EMP2) and FAK mediated collagen gel contraction in ARPE-19 cells","volume":"102","author":"Morales","year":"2012","journal-title":"Exp Eye Res"},{"key":"10.1016\/j.juro.2013.12.001_bib28","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1158\/1078-0432.CCR-04-2107","article-title":"Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors","volume":"11","author":"Huang","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.juro.2013.12.001_bib29","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0140-6736(02)09552-1","article-title":"Malignant effusions and immunogenic tumour-derived exosomes","volume":"360","author":"Andre","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.juro.2013.12.001_bib30","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ceb.2006.08.011","article-title":"Integrin-regulated FAK-Src signaling in normal and cancer cells","volume":"18","author":"Mitra","year":"2006","journal-title":"Curr Opin Cell Biol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471306076X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002253471306076X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2013.12.001","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:30:04Z","timestamp":1651203004000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2013.12.001"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["10.1016\/j.juro.2013.12.001"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2013.12.001","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7]]}}}